DE69026881D1 - 4-Substituiertes 17-beta-(Cyclopropyl-amino)-androst-5-en-3-beta-ol und seine Derivate, verwendbar als Inhibitoren der C17-20-Lyase - Google Patents

4-Substituiertes 17-beta-(Cyclopropyl-amino)-androst-5-en-3-beta-ol und seine Derivate, verwendbar als Inhibitoren der C17-20-Lyase

Info

Publication number
DE69026881D1
DE69026881D1 DE69026881T DE69026881T DE69026881D1 DE 69026881 D1 DE69026881 D1 DE 69026881D1 DE 69026881 T DE69026881 T DE 69026881T DE 69026881 T DE69026881 T DE 69026881T DE 69026881 D1 DE69026881 D1 DE 69026881D1
Authority
DE
Germany
Prior art keywords
beta
androst
cyclopropylamino
substituted
lyase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69026881T
Other languages
English (en)
Other versions
DE69026881T2 (de
Inventor
Michael R Angelastro
Thomas R Blohm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69026881D1 publication Critical patent/DE69026881D1/de
Application granted granted Critical
Publication of DE69026881T2 publication Critical patent/DE69026881T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69026881T 1989-08-15 1990-08-10 4-Substituiertes 17-beta-(Cyclopropyl-amino)-androst-5-en-3-beta-ol und seine Derivate, verwendbar als Inhibitoren der C17-20-Lyase Expired - Fee Related DE69026881T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/394,025 US4966898A (en) 1989-08-15 1989-08-15 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors

Publications (2)

Publication Number Publication Date
DE69026881D1 true DE69026881D1 (de) 1996-06-13
DE69026881T2 DE69026881T2 (de) 1996-09-12

Family

ID=23557240

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69026881T Expired - Fee Related DE69026881T2 (de) 1989-08-15 1990-08-10 4-Substituiertes 17-beta-(Cyclopropyl-amino)-androst-5-en-3-beta-ol und seine Derivate, verwendbar als Inhibitoren der C17-20-Lyase

Country Status (20)

Country Link
US (1) US4966898A (de)
EP (1) EP0413270B1 (de)
JP (1) JP2879703B2 (de)
KR (1) KR910004649A (de)
CN (1) CN1050196A (de)
AT (1) ATE137761T1 (de)
AU (1) AU628209B2 (de)
CA (1) CA2023012C (de)
DD (1) DD299650A5 (de)
DE (1) DE69026881T2 (de)
ES (1) ES2088928T3 (de)
FI (1) FI95804C (de)
HU (1) HUT55029A (de)
IE (1) IE72516B1 (de)
IL (1) IL95358A (de)
NO (1) NO903564L (de)
NZ (1) NZ234856A (de)
PH (1) PH27098A (de)
PT (1) PT94993B (de)
ZA (1) ZA906308B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966897A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US5604213A (en) * 1992-03-31 1997-02-18 British Technology Group Limited 17-substituted steroids useful in cancer treatment
NZ249911A (en) * 1992-03-31 1996-06-25 British Tech Group 17-(3-pyridyl) substituted steroids and use in pharmaceutical compositions
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US6365597B1 (en) 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
IL152696A0 (en) * 2000-06-09 2003-06-24 Bayer Cropscience Sa Process for the preparation of pesticidal compounds
SI1334106T1 (sl) 2000-11-17 2006-10-31 Takeda Pharmaceutical Imidazolni derivati, njihov proizvodni postopek in njihova uporaba
US6960586B2 (en) 2000-11-20 2005-11-01 Takeda Pharmaceutical Company Limited Imidazole derivatives, process for their preparation and their use
CA2431171A1 (en) 2000-12-08 2002-06-13 Takeda Chemical Industries, Ltd. Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
JO2892B1 (en) 2009-06-26 2015-09-15 نوفارتيس ايه جي CYP inhibitors 17
JP2011098893A (ja) * 2009-11-04 2011-05-19 Sumitomo Chemical Co Ltd テストステロンの生合成を抑制するための化合物の使用およびその化合物
WO2012018948A2 (en) 2010-08-04 2012-02-09 Pellficure Pharmaceuticals, Inc. Novel treatment of prostate carcinoma
US8946260B2 (en) 2010-09-16 2015-02-03 Novartis Ag 17α-hydroxylase/C17,20-lyase inhibitors
US9029399B2 (en) 2011-04-28 2015-05-12 Novartis Ag 17α-hydroxylase/C17,20-lyase inhibitors
EP2968219B1 (de) 2013-03-14 2019-04-24 Pellficure Pharmaceuticals, Inc. Neuartige therapie gegen prostatakarzinome
CA2960750A1 (en) 2014-09-12 2016-03-17 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
MA45780A (fr) 2016-07-29 2019-06-05 Janssen Pharmaceutica Nv Méthodes de traitement du cancer de la prostate
EP3528799A1 (de) 2016-10-24 2019-08-28 Pellficure Pharmaceuticals, Inc. Pharmazeutische zusammensetzungen aus 5-hydroxy-2-methylnaphthalen-1,4-dion

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3107254A (en) * 1960-10-05 1963-10-15 Upjohn Co 17beta-dialkylamino-17-cyanosteroids and their 17alpha-alkyl, alkylene and alkyne derivatives
US3097200A (en) * 1962-01-03 1963-07-09 Syntex Corp 17-aminoandrostanes
NL302932A (de) * 1962-12-31
NZ224288A (en) * 1987-04-22 1989-12-21 Merrell Dow Pharma 17b-(cyclopropylamino)androst-5-en-3b-ol and related compounds and methods using these for treatment of non-humans
US4966897A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors

Also Published As

Publication number Publication date
KR910004649A (ko) 1991-03-29
EP0413270A3 (en) 1992-05-20
PH27098A (en) 1993-02-26
IL95358A (en) 1995-03-30
IE72516B1 (en) 1997-04-23
PT94993B (pt) 1997-07-31
DD299650A5 (de) 1992-04-30
EP0413270B1 (de) 1996-05-08
IE902942A1 (en) 1991-02-27
US4966898A (en) 1990-10-30
ATE137761T1 (de) 1996-05-15
JP2879703B2 (ja) 1999-04-05
JPH0383998A (ja) 1991-04-09
ES2088928T3 (es) 1996-10-01
FI904035A0 (fi) 1990-08-15
NZ234856A (en) 1992-08-26
PT94993A (pt) 1991-04-18
HU905004D0 (en) 1991-01-28
IL95358A0 (en) 1991-06-30
ZA906308B (en) 1991-06-26
CA2023012A1 (en) 1991-02-16
CN1050196A (zh) 1991-03-27
AU628209B2 (en) 1992-09-10
EP0413270A2 (de) 1991-02-20
HUT55029A (en) 1991-04-29
FI95804B (fi) 1995-12-15
AU6087790A (en) 1991-02-21
NO903564D0 (no) 1990-08-14
DE69026881T2 (de) 1996-09-12
FI95804C (fi) 1996-03-25
CA2023012C (en) 2001-07-03
NO903564L (no) 1991-02-18

Similar Documents

Publication Publication Date Title
DE69026881D1 (de) 4-Substituiertes 17-beta-(Cyclopropyl-amino)-androst-5-en-3-beta-ol und seine Derivate, verwendbar als Inhibitoren der C17-20-Lyase
ATE67211T1 (de) C17-20-lyase-inhibitoren.
DE69027262T2 (de) 4-Substitutiertes 17-beta-(Cyclopropyloxy)androst-5-en-3-beta-ol und seine Derivate, verwendbar als Inhibitoren der C17-20-Lyase
ATE298250T1 (de) Verfahren und potenzierte zusammensetzung zur behandlung von migräne
DK0556332T3 (da) Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet
FI100240B (fi) Menetelmä keskushermostoon vaikuttavien substituoitujen syklohekseenie n valmistamiseksi
DE69504198T2 (de) Substituierte alkyldiaminderivate und ihre verwendung als tachykinin antagonisten
DE69810340D1 (de) Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
CA1262906C (en) 3-(2-FUROYL)-5-ALCOXYCARBONYL-2,6-DIMETHYL-4-(2-NITROPHENYL)-1,4-DIHYDROPYRIDINES, CALCIUM ANTAGONISTS
HUP0001118A2 (hu) N-szubsztituált pirrolidinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee